Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Osman Celik and Rifat Emral.
Osman Celik
Connection Strength
0.477
Rifat Emral
  1. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study. Diabetes Ther. 2021 Nov; 12(11):2857-2870.
    View in: PubMed
    Score: 0.241
  2. Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity). Exp Clin Endocrinol Diabetes. 2022 Feb; 130(2):115-124.
    View in: PubMed
    Score: 0.060
  3. Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia). Endocrine. 2021 08; 73(2):261-269.
    View in: PubMed
    Score: 0.060
  4. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia). J Diabetes. 2021 Jul; 13(7):585-595.
    View in: PubMed
    Score: 0.059
  5. Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul. Diabetes Res Clin Pract. 2021 Apr; 174:108753.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.